OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Deciphering the cellular mechanisms underlying fibrosis-associated diseases and therapeutic avenues
Hua Miao, Xiaqing Wu, Dandan Zhang, et al.
Pharmacological Research (2020) Vol. 163, pp. 105316-105316
Closed Access | Times Cited: 42

Showing 26-50 of 42 citing articles:

Cellular heterogeneity and plasticity during NAFLD progression
Hyunju Park, Juyong Choi, Hyun-Mi Kim, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 6

Targeting Interleukin-17 as a Novel Treatment Option for Fibrotic Diseases
Margherita Sisto, Sabrina Lisi
Journal of Clinical Medicine (2023) Vol. 13, Iss. 1, pp. 164-164
Open Access | Times Cited: 6

The Aryl Hydrocarbon Receptor Ligand FICZ Improves Left Ventricular Remodeling and Cardiac Function at the Onset of Pressure Overload-Induced Heart Failure in Mice
María Tamayo, Laura Martín‐Nunes, Maria J. Piedras, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5403-5403
Open Access | Times Cited: 10

USP22 aggravated diabetic renal tubulointerstitial fibrosis progression through deubiquitinating and stabilizing Snail1
Xilin Zhao, Xuelan He, Wentao Wei, et al.
European Journal of Pharmacology (2023) Vol. 947, pp. 175671-175671
Closed Access | Times Cited: 5

Forsythiaside B inhibits myocardial fibrosis via down regulating TGF-β1/Smad signaling pathway
Jing Sun, Jiaxin Zhu, Lei Chen, et al.
European Journal of Pharmacology (2021) Vol. 908, pp. 174354-174354
Closed Access | Times Cited: 11

Piezo1:the potential new therapeutic target for fibrotic diseases
Xin Liu, Wei-pin Niu, Shuqing Zhao, et al.
Progress in Biophysics and Molecular Biology (2023) Vol. 184, pp. 42-49
Open Access | Times Cited: 4

Epigenetic Regulation of EMP/EMT-Dependent Fibrosis
Margherita Sisto, Sabrina Lisi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2775-2775
Open Access | Times Cited: 1

Cell Death in Acute Organ Injury and Fibrosis
Taro Yasuma, Esteban C. Gabazza
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3930-3930
Open Access | Times Cited: 1

Label‐free three‐dimensional imaging and quantitative analysis of living fibroblasts and myofibroblasts by holotomographic microscopy
Francesca Sbrana, Flaminia Chellini, Alessia Tani, et al.
Microscopy Research and Technique (2024) Vol. 87, Iss. 11, pp. 2757-2773
Closed Access | Times Cited: 1

Platelet‐rich plasma affects gap junctional features in myofibroblasts in vitro via vascular endothelial growth factor (VEGF)‐A/VEGF receptor
Chiara Sassoli, Rachele Garella, Flaminia Chellini, et al.
Experimental Physiology (2021) Vol. 107, Iss. 2, pp. 106-121
Open Access | Times Cited: 10

Long Non-Coding RNAs in Oral Submucous Fibrosis: Their Functional Mechanisms and Recent Research Progress
Yaodong He, Wei Wang, Pingping Jiang, et al.
Journal of Inflammation Research (2021) Vol. Volume 14, pp. 5787-5800
Open Access | Times Cited: 5

Ferroptosis: A New Strategy for the Treatment of Fibrotic Diseases
Zhuo Pei, Jing Fan, Maolin Tang, et al.
Advanced Biology (2024)
Open Access

Advances in macrophage-myofibroblast transformation in fibrotic diseases
Jiaqi Ban, Li-Hong Ao, Xiu He, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access

Fibrosis: From Cellular and Molecular Targets to Therapeutic Strategies
Chiara Sassoli
Current Molecular Medicine (2022) Vol. 22, Iss. 3, pp. 193-195
Closed Access | Times Cited: 2

Total sesquiterpenoids from Eupatorium lindleyanum DC. attenuate bleomycin-induced lung fibrosis by suppressing myofibroblast transition
Xionghua Sun, Mei Zhu, Wei Xia, et al.
Fitoterapia (2023) Vol. 169, pp. 105567-105567
Closed Access

Previous Page - Page 2

Scroll to top